Status:
ENROLLING_BY_INVITATION
AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data
Lead Sponsor:
Qun Zhao
Collaborating Sponsors:
Renmin Hospital of Wuhan University
Nanjing University School of Medicine
Conditions:
Gastric Cancer Adenocarcinoma Metastatic
Lymph Node Metastasis
Eligibility:
All Genders
18-80 years
Brief Summary
This study aims to develop and validate an artificial intelligence (AI) system that can predict whether lymph node metastasis has occurred in patients with gastric cancer before surgery. Using preoper...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Histologically confirmed gastric adenocarcinoma
- Scheduled for curative-intent gastrectomy with lymphadenectomy
- Completed preoperative imaging with contrast-enhanced CT or MRI
- Available preoperative biopsy pathology report
- Able and willing to provide written informed consent
Exclusion
- Evidence of distant metastasis on preoperative imaging
- Prior chemotherapy, radiotherapy, or major abdominal surgery
- Severe comorbidities contraindicating surgery
- Incomplete or poor-quality preoperative imaging or pathology data
- Pregnancy or lactation
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT06957678
Start Date
January 1 2025
End Date
December 31 2025
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Fourth Hospital of Hebei Medical University
Shijiazhuang, None Selected, China, 050011